Skip to main content

Table 1 Baseline characteristics of type 2 diabetic patients

From: Lower hypoglycemic but higher antiatherogenic effects of bitter melon than glibenclamide in type 2 diabetic patients

Parameters Bitter melon 2 g/day Bitter melon 4 g/day Glibenclamide (5 mg/day)
  (Group I) (Group II) (Group III)
N 30 31 29
Sex, M/F 21/9 (70/30) 20/11 (65/35) 18/11 (62/38)
Age (y) 51.90±10.50 52±11.40 52.20±8.70
Time since diagnosis of diabetes (yr)
0-1 22 (73) 24 (77) 20 (70)
≤2 8 (27) 7 (23) 9 (30)
BMI (Kg/m2) 25.2±1.70 25.7±2.40 25±2.20